73 related articles for article (PubMed ID: 22250046)
1. The impact of the genetic background on the genome make-up of tumor cells.
Falck E; Behboudi A; Klinga-Levan K
Genes Chromosomes Cancer; 2012 May; 51(5):438-46. PubMed ID: 22250046
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model.
Roshani L; Mallon P; Sjostrand E; Wedekind D; Szpirer J; Szpirer C; Hedrich HJ; Klinga-Levan K
Cancer Genet Cytogenet; 2005 Apr; 158(2):137-41. PubMed ID: 15796960
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization.
Hamta A; Adamovic T; Heloua K; Levan G
Cancer Genet Cytogenet; 2005 Jun; 159(2):123-8. PubMed ID: 15899383
[TBL] [Abstract][Full Text] [Related]
4. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
Karlsson S; Holmberg E; Askerlund A; Levan KK
Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
[TBL] [Abstract][Full Text] [Related]
5. Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas.
Nordlander C; Samuelson E; Klinga-Levan K; Behboudi A
Adv Exp Med Biol; 2008; 617():519-25. PubMed ID: 18497077
[TBL] [Abstract][Full Text] [Related]
6. Allelic imbalance on chromosome 10 in rat endometrial adenocarcinomas.
Nordlander C; Behboudi A; Levan G; Levan KK
Cancer Genet Cytogenet; 2005 Jan; 156(2):158-66. PubMed ID: 15642397
[TBL] [Abstract][Full Text] [Related]
7. Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors.
Samuelson E; Nordlander C; Levan G; Behboudi A
Adv Exp Med Biol; 2008; 617():511-7. PubMed ID: 18497076
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization.
Helou K; Walentinsson A; Beckmann B; Johansson A; Hedrich HJ; Szpirer C; Klinga-Levan K; Levan G
Cancer Genet Cytogenet; 2001 Jun; 127(2):118-27. PubMed ID: 11425450
[TBL] [Abstract][Full Text] [Related]
9. Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinoma as revealed by combined BAC/PAC FISH, chromosome painting, zoo-FISH, and allelotyping.
Adamovic T; Trossö F; Roshani L; Andersson L; Petersen G; Rajaei S; Helou K; Levan G
Genes Chromosomes Cancer; 2005 Oct; 44(2):139-53. PubMed ID: 15942940
[TBL] [Abstract][Full Text] [Related]
10. Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model.
Roshani L; Wedekind D; Szpirer J; Taib Z; Szpirer C; Beckmann B; Rivière M; Hedrich HJ; Klinga-Levan K
Int J Cancer; 2001 Dec; 94(6):795-9. PubMed ID: 11745480
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of human endometrial adenocarcinoma in an inbred rat model.
Karlsson S; Klinga-Levan K
Adv Exp Med Biol; 2008; 617():503-9. PubMed ID: 18497075
[TBL] [Abstract][Full Text] [Related]
12. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
[TBL] [Abstract][Full Text] [Related]
13. Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization.
Walentinsson A; Helou K; Wallenius V; Hedrich HJ; Szpirer C; Levan G
Cancer Res; 2001 Nov; 61(22):8263-73. PubMed ID: 11719459
[TBL] [Abstract][Full Text] [Related]
14. High-density marker loss of heterozygosity analysis of rat chromosome 10 in endometrial adenocarcinoma.
Behboudi A; Levan G; Hedrich HJ; Klinga-Levan K
Genes Chromosomes Cancer; 2001 Dec; 32(4):330-41. PubMed ID: 11746974
[TBL] [Abstract][Full Text] [Related]
15. Deriving evolutionary tree models of the oncogenesis of endometrial adenocarcinoma.
Chen L; Nordlander C; Behboudi A; Olsson B; Levan KK
Int J Cancer; 2007 Jan; 120(2):292-6. PubMed ID: 17066454
[TBL] [Abstract][Full Text] [Related]
16. Analysis of chromosome 10 aberrations in rat endometrial cancer-evidence for a tumor suppressor locus distal to Tp53.
Nordlander C; Karlsson S; Karlsson A; Sjöling A; Winnes M; Klinga-Levan K; Behboudi A
Int J Cancer; 2007 Apr; 120(7):1472-81. PubMed ID: 17245700
[TBL] [Abstract][Full Text] [Related]
17. Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer.
Adamovic T; Hamta A; Roshani L; Lü X; Röhme D; Helou K; Klinga-Levan K; Levan G
Cancer Genet Cytogenet; 2008 Jul; 184(1):9-21. PubMed ID: 18558284
[TBL] [Abstract][Full Text] [Related]
18. Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization.
Samuelson E; Levan K; Adamovic T; Levan G; Horvath G
Cancer Genet Cytogenet; 2008 Feb; 181(1):25-30. PubMed ID: 18262049
[TBL] [Abstract][Full Text] [Related]
19. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
[TBL] [Abstract][Full Text] [Related]
20. SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.
Falck E; Hedberg C; Klinga-Levan K; Behboudi A
Cancer Cell Int; 2011 Jun; 11(1):20. PubMed ID: 21708004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
